| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSS2000040 | 重组人源抗狂犬病毒单抗注射液 | Ormutivimab | Injection | Biological Products(1) | New Drug Application | 2020-07-04 | 华北制药金坦生物技术股份有限公司,华北制药集团新药研究开发有限责任公司 | Certificate Issued | 2021-08-13 | view |